Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Trueblue ( (TBI) ) has shared an announcement.
On January 30, 2026, TrueBlue, Inc. amended its existing syndicated credit agreement, converting it from a cash-flow based revolving facility to an asset-based lending structure that ties borrowing capacity to a defined borrowing base of eligible accounts and unbilled receivables, subject to availability reserves and evolving covenant triggers tied to excess availability and fixed charge coverage. The Second Amendment reduces the company’s revolving line of credit commitment from $255 million to $175 million, while preserving an option to upsize by $150 million with lender approval and leaving pricing, sub-limits, collateral security, and maturity terms unchanged, signaling a shift toward collateral-focused financing that may influence TrueBlue’s liquidity management and covenant profile without materially altering its cost of capital.
The most recent analyst rating on (TBI) stock is a Hold with a $5.50 price target. To see the full list of analyst forecasts on Trueblue stock, see the TBI Stock Forecast page.
Spark’s Take on TBI Stock
According to Spark, TipRanks’ AI Analyst, TBI is a Neutral.
The score is held down primarily by weak financial performance (losses and negative operating/free cash flow) and a bearish technical setup (price below key moving averages and negative MACD). The latest earnings call adds some support via strong year-over-year revenue growth, cost reductions, and positive Q4 growth guidance, but margin pressure and ongoing losses keep the overall rating below average.
To see Spark’s full report on TBI stock, click here.
More about Trueblue
Average Trading Volume: 202,834
Technical Sentiment Signal: Sell
Current Market Cap: $160.5M
Learn more about TBI stock on TipRanks’ Stock Analysis page.